 |
|
 |
   |
   |
|
 |
|
RESPeRATE
Blood Pressure Lowering Device
Resperate is a non-drug option to further lower patients' high blood pressure with no side effects and no drug interactions. Results of 6 clinical studies have been published in peer-reviewed journals, including the American Journal of Hypertension. Resperate delivers an average 14/9 mmHg sustained blood pressure reduction within 8 weeks of proper use (15 minutes a day, 3-4 times per week). The Scientific Advisory Board for Resperate includes many of the world's leading hypertension experts, including past presidents of the American, European and International Societies of Hypertension. The underlying physiological mechanism of action of Low Frequency Respiratory Pacing technology, as deployed in Resperate, was recently discussed in the AHA Hypertension Primer, Third Edition textbook. A reprint of the relevant chapter is available by fax request.
 |
||||
|
||||
home 
services 
what's
new 
media
center sitemap health screening products contact
us
hypertension management. ultrasound dopplers lipid management glucose management weight management anticoagulation monitoring anemia hemoglobin analyzer
telemedicine monitoring devices respiratory care
All rights reserved Copyright © 2009
Design by www.daslweb.com
